Pre-treatment mean DCE parameters in 43 primary sites and 40 nodal sites correlated with SF or SC at the same SCC site, based on a minimum of 2 year clinical follow-up.

Low-grade screen-detected ductal carcinoma in situ progresses more slowly than high-grade lesions: evidence from an international multi-centre study.

Ponti, A.
Ronco, G.
Lynge, E.
Tomatis, M.
Anttila, A.
Ascunce, N.
Broeders, M.
Bulliard, J.L.
Castellano, I.
Fitzpatrick, P.
Frigerio, A.
Hofvind, S.
Májek, O.
Segnan, N.
Taplin, S.

October 2019

Nuclear grade is an important indicator of the biological behaviour of ductal carcinoma in situ (DCI...

Demographic, clinical, MRI characteristics and current disease-modifying therapies.

Kishore Malyavantham (753580)
Bianca Weinstock-Guttman (105396)
Lakshmanan Suresh (753581)
Robert Zivadinov (105393)
Thomas Shanahan (753582)
Darlene Badgett (105406)
Murali Ramanathan (87589)

June 2015

* All continuous variables (age, disease duration, T2-LV, T1-LV) are mean ± standard deviation. F...

Density plots for the top 6 most important predictive features selected by the random forest model.

Zamir G. Merali (6556172)
Christopher D. Witiw (6556175)
Jetan H. Badhiwala (6518234)
Jefferson R. Wilson (331489)
Michael G. Fehlings (142465)

April 2019

These density plots demonstrate the distribution of the key features between the patients who did (b...

Pre-treatment mean DCE, volumes and clinical parameters in 83 SCC sites (primary plus nodal) correlated with SF or SC at the same site, based on a minimum of 2 year clinical follow-up.

Ann D. King (392031)
Steven Kwok Keung Chow (392028)
Kwok-Hung Yu (835297)
Frankie Kwok Fai Mo (835298)
David K. W. Yeung (835299)
Jing Yuan (217967)
Benjamin King Hong Law (835300)
Kunwar S. Bhatia (513424)
Alexander C. Vlantis (835301)
Anil T. Ahuja (296899)

December 2015

± Standard deviation.Pre-treatment mean DCE, volumes and clinical parameters in 83 SCC sit...

Post treatment residual mass in 33 SCC sites (primary plus nodal): mean DCE and volumes (and % change when compared to pre-treatment), and clinical parameters for SC residual masses and SF residual masses, based on a minimum of 2 year clinical follow-up.

Ann D. King (392031)
Steven Kwok Keung Chow (392028)
Kwok-Hung Yu (835297)
Frankie Kwok Fai Mo (835298)
David K. W. Yeung (835299)
Jing Yuan (217967)
Benjamin King Hong Law (835300)
Kunwar S. Bhatia (513424)
Alexander C. Vlantis (835301)
Anil T. Ahuja (296899)

December 2015

± Standard deviation.Post treatment residual mass in 33 SCC sites (primary plus nodal): me...

Mean (± standard deviation) coordinates and stimulation parameters of 29 patients with GPm DBS and 42 patients with STN DBS at 6 months postoperatively.

Claire Haegelen (251018)
Clément Baumgarten (5513645)
Jean-François Houvenaghel (811219)
Yulong Zhao (562888)
Julie Péron (251008)
Sophie Drapier (251039)
Pierre Jannin (811222)
Xavier Morandi (97533)

July 2018

Mean (± standard deviation) coordinates and stimulation parameters of 29 patients with GPm DBS an...

The correlations between the centrality (DC and EC) metrics within the entire SMN and the clinical variables in the remitting phase of RRMS patients.

Ying Zhuang (341742)
Fuqing Zhou (593535)
Honghan. Gong (760597)

June 2015

The correlations between the centrality (DC and EC) metrics within the entire SMN and the clinica...

Reference outcomes for Usual Care and New Intervention, per patient after 12 cycles—Mean (Standard deviation)a.

Pepijn Vemer (849576)
Maiwenn J. Al (3713464)
Mark Oppe (3515177)
Maureen P. M. H. Rutten-van Mölken (3713467)

February 2017

Reference outcomes for Usual Care and New Intervention, per patient after 12 cycles—Mean (Standar...

Clinical characteristics of the 648 patients referred to direct CT scan from general practice.

Louise Mahncke Guldbrandt (657312)
Torben Riis Rasmussen (657313)
Finn Rasmussen (184906)
Peter Vedsted (388354)

November 2014

1Of all patients.2Listed in DCR before study start (either ≥10 years...

Predictors of change in PCE between baseline and follow-up among operated cases.

Hannah Kuper (25751)
Sarah Polack (332101)
Wanjiku Mathenge (336328)
Cristina Eusebio (359966)
Zakia Wadud (359967)
Mamunur Rashid (359968)
Allen Foster (94749)

February 2013

Predictors of change in PCE between baseline and follow-up among operated cases.</p

Predictors of RTW measured with c-statistics (area under ROC curve) with 95% CI at 12 weeks and one year after PCI.

Karin Biering (298336)
Torsten Toftegaard Nielsen (298339)
Kurt Rasmussen (298342)
Troels Niemann (298344)
Niels Henrik Hjollund (298348)

February 2013

Predictors of RTW measured with c-statistics (area under ROC curve) with 95% CI at 12 weeks and o...

Patient median Hb coefficients of variation and median Hb ranges for two 6-month periods before and three 6-month periods after the start of the CQI process.

Jonathan A. Lorch (566667)
Victor E. Pollak (566668)

May 2014

Patient median Hb coefficients of variation and median Hb ranges for two 6-month periods before a...

SCORAD at 6, 12 and 36 months, adjusted mean ±95% confidence interval (CI) per group from multilevel models (ANCOVA) with fixed effects age, gender, baseline value, TIS-score, social status, expectation of the parents, and random effect physician (lower values indicate lower disease severity).

Stephanie Roll (168590)
Thomas Reinhold (285933)
Daniel Pach (172397)
Benno Brinkhaus (197332)
Katja Icke (197333)
Doris Staab (193176)
Tanja Jäckel (285937)
Karl Wegscheider (66415)
Stefan N. Willich (182111)
Claudia M. Witt (172436)

February 2013

SCORAD at 6, 12 and 36 months, adjusted mean ±95% confidence interval (CI) per group from multile...

DCCD and standard clinical prognostic factors.

Anja Ulmer (524176)
Klaus Dietz (44087)
Isabelle Hodak (524177)
Bernhard Polzer (503745)
Sebastian Scheitler (524178)
Murat Yildiz (524179)
Zbigniew Czyz (524180)
Petra Lehnert (524181)
Tanja Fehm (23618)
Christian Hafner (332556)
Stefan Schanz (524182)
Martin Röcken (524183)
Claus Garbe (48881)
Helmut Breuninger (191128)
Gerhard Fierlbeck (524184)
Christoph A. Klein (503744)

February 2014

For all panels, the red lines indicate the medians, and the black lines the 25th and 75th percent...

SCORAD differences to baseline at 6, 12, and 36 months, adjusted mean ±95% confidence interval (CI) per group from repeated measures multilevel model with time and time-by-group interaction and fixed effects age, gender, baseline value, TIS-score, social status, expectation of the parents, and random effect physician; post-hoc analysis on complete cases (patients with SCORAD data available for all time points); lower mean values indicate greater improvement.

Stephanie Roll (168590)
Thomas Reinhold (285933)
Daniel Pach (172397)
Benno Brinkhaus (197332)
Katja Icke (197333)
Doris Staab (193176)
Tanja Jäckel (285937)
Karl Wegscheider (66415)
Stefan N. Willich (182111)
Claudia M. Witt (172436)

February 2013

SCORAD differences to baseline at 6, 12, and 36 months, adjusted mean ±95% confidence interval (C...

Low-grade screen-detected ductal carcinoma in situ progresses more slowly than high-grade lesions: evidence from an international multi-centre study.

Ponti, A.
Ronco, G.
Lynge, E.
Tomatis, M.
Anttila, A.
Ascunce, N.
Broeders, M.
Bulliard, J.L.
Castellano, I.
Fitzpatrick, P.
Frigerio, A.
Hofvind, S.
Májek, O.
Segnan, N.
Taplin, S.

October 2019

Nuclear grade is an important indicator of the biological behaviour of ductal carcinoma in situ (DCI...

Demographic, clinical, MRI characteristics and current disease-modifying therapies.

Kishore Malyavantham (753580)
Bianca Weinstock-Guttman (105396)
Lakshmanan Suresh (753581)
Robert Zivadinov (105393)
Thomas Shanahan (753582)
Darlene Badgett (105406)
Murali Ramanathan (87589)

June 2015

* All continuous variables (age, disease duration, T2-LV, T1-LV) are mean ± standard deviation. F...

Density plots for the top 6 most important predictive features selected by the random forest model.

Zamir G. Merali (6556172)
Christopher D. Witiw (6556175)
Jetan H. Badhiwala (6518234)
Jefferson R. Wilson (331489)
Michael G. Fehlings (142465)

April 2019

These density plots demonstrate the distribution of the key features between the patients who did (b...

Pre-treatment mean DCE, volumes and clinical parameters in 83 SCC sites (primary plus nodal) correlated with SF or SC at the same site, based on a minimum of 2 year clinical follow-up.

Ann D. King (392031)
Steven Kwok Keung Chow (392028)
Kwok-Hung Yu (835297)
Frankie Kwok Fai Mo (835298)
David K. W. Yeung (835299)
Jing Yuan (217967)
Benjamin King Hong Law (835300)
Kunwar S. Bhatia (513424)
Alexander C. Vlantis (835301)
Anil T. Ahuja (296899)

December 2015

± Standard deviation.Pre-treatment mean DCE, volumes and clinical parameters in 83 SCC sit...

Post treatment residual mass in 33 SCC sites (primary plus nodal): mean DCE and volumes (and % change when compared to pre-treatment), and clinical parameters for SC residual masses and SF residual masses, based on a minimum of 2 year clinical follow-up.

Ann D. King (392031)
Steven Kwok Keung Chow (392028)
Kwok-Hung Yu (835297)
Frankie Kwok Fai Mo (835298)
David K. W. Yeung (835299)
Jing Yuan (217967)
Benjamin King Hong Law (835300)
Kunwar S. Bhatia (513424)
Alexander C. Vlantis (835301)
Anil T. Ahuja (296899)

December 2015

± Standard deviation.Post treatment residual mass in 33 SCC sites (primary plus nodal): me...

Mean (± standard deviation) coordinates and stimulation parameters of 29 patients with GPm DBS and 42 patients with STN DBS at 6 months postoperatively.

Claire Haegelen (251018)
Clément Baumgarten (5513645)
Jean-François Houvenaghel (811219)
Yulong Zhao (562888)
Julie Péron (251008)
Sophie Drapier (251039)
Pierre Jannin (811222)
Xavier Morandi (97533)

July 2018

Mean (± standard deviation) coordinates and stimulation parameters of 29 patients with GPm DBS an...

The correlations between the centrality (DC and EC) metrics within the entire SMN and the clinical variables in the remitting phase of RRMS patients.

Ying Zhuang (341742)
Fuqing Zhou (593535)
Honghan. Gong (760597)

June 2015

The correlations between the centrality (DC and EC) metrics within the entire SMN and the clinica...

Reference outcomes for Usual Care and New Intervention, per patient after 12 cycles—Mean (Standard deviation)a.

Pepijn Vemer (849576)
Maiwenn J. Al (3713464)
Mark Oppe (3515177)
Maureen P. M. H. Rutten-van Mölken (3713467)

February 2017

Reference outcomes for Usual Care and New Intervention, per patient after 12 cycles—Mean (Standar...

Clinical characteristics of the 648 patients referred to direct CT scan from general practice.

Louise Mahncke Guldbrandt (657312)
Torben Riis Rasmussen (657313)
Finn Rasmussen (184906)
Peter Vedsted (388354)

November 2014

1Of all patients.2Listed in DCR before study start (either ≥10 years...

Predictors of change in PCE between baseline and follow-up among operated cases.

Hannah Kuper (25751)
Sarah Polack (332101)
Wanjiku Mathenge (336328)
Cristina Eusebio (359966)
Zakia Wadud (359967)
Mamunur Rashid (359968)
Allen Foster (94749)

February 2013

Predictors of change in PCE between baseline and follow-up among operated cases.</p

Predictors of RTW measured with c-statistics (area under ROC curve) with 95% CI at 12 weeks and one year after PCI.

Karin Biering (298336)
Torsten Toftegaard Nielsen (298339)
Kurt Rasmussen (298342)
Troels Niemann (298344)
Niels Henrik Hjollund (298348)

February 2013

Predictors of RTW measured with c-statistics (area under ROC curve) with 95% CI at 12 weeks and o...

Patient median Hb coefficients of variation and median Hb ranges for two 6-month periods before and three 6-month periods after the start of the CQI process.

Jonathan A. Lorch (566667)
Victor E. Pollak (566668)

May 2014

Patient median Hb coefficients of variation and median Hb ranges for two 6-month periods before a...

SCORAD at 6, 12 and 36 months, adjusted mean ±95% confidence interval (CI) per group from multilevel models (ANCOVA) with fixed effects age, gender, baseline value, TIS-score, social status, expectation of the parents, and random effect physician (lower values indicate lower disease severity).

Stephanie Roll (168590)
Thomas Reinhold (285933)
Daniel Pach (172397)
Benno Brinkhaus (197332)
Katja Icke (197333)
Doris Staab (193176)
Tanja Jäckel (285937)
Karl Wegscheider (66415)
Stefan N. Willich (182111)
Claudia M. Witt (172436)

February 2013

SCORAD at 6, 12 and 36 months, adjusted mean ±95% confidence interval (CI) per group from multile...

DCCD and standard clinical prognostic factors.

Anja Ulmer (524176)
Klaus Dietz (44087)
Isabelle Hodak (524177)
Bernhard Polzer (503745)
Sebastian Scheitler (524178)
Murat Yildiz (524179)
Zbigniew Czyz (524180)
Petra Lehnert (524181)
Tanja Fehm (23618)
Christian Hafner (332556)
Stefan Schanz (524182)
Martin Röcken (524183)
Claus Garbe (48881)
Helmut Breuninger (191128)
Gerhard Fierlbeck (524184)
Christoph A. Klein (503744)

February 2014

For all panels, the red lines indicate the medians, and the black lines the 25th and 75th percent...

SCORAD differences to baseline at 6, 12, and 36 months, adjusted mean ±95% confidence interval (CI) per group from repeated measures multilevel model with time and time-by-group interaction and fixed effects age, gender, baseline value, TIS-score, social status, expectation of the parents, and random effect physician; post-hoc analysis on complete cases (patients with SCORAD data available for all time points); lower mean values indicate greater improvement.

Stephanie Roll (168590)
Thomas Reinhold (285933)
Daniel Pach (172397)
Benno Brinkhaus (197332)
Katja Icke (197333)
Doris Staab (193176)
Tanja Jäckel (285937)
Karl Wegscheider (66415)
Stefan N. Willich (182111)
Claudia M. Witt (172436)

February 2013

SCORAD differences to baseline at 6, 12, and 36 months, adjusted mean ±95% confidence interval (C...

Low-grade screen-detected ductal carcinoma in situ progresses more slowly than high-grade lesions: evidence from an international multi-centre study.

Ponti, A.
Ronco, G.
Lynge, E.
Tomatis, M.
Anttila, A.
Ascunce, N.
Broeders, M.
Bulliard, J.L.
Castellano, I.
Fitzpatrick, P.
Frigerio, A.
Hofvind, S.
Májek, O.
Segnan, N.
Taplin, S.

October 2019

Nuclear grade is an important indicator of the biological behaviour of ductal carcinoma in situ (DCI...

Demographic, clinical, MRI characteristics and current disease-modifying therapies.

Kishore Malyavantham (753580)
Bianca Weinstock-Guttman (105396)
Lakshmanan Suresh (753581)
Robert Zivadinov (105393)
Thomas Shanahan (753582)
Darlene Badgett (105406)
Murali Ramanathan (87589)

June 2015

* All continuous variables (age, disease duration, T2-LV, T1-LV) are mean ± standard deviation. F...

Density plots for the top 6 most important predictive features selected by the random forest model.

Zamir G. Merali (6556172)
Christopher D. Witiw (6556175)
Jetan H. Badhiwala (6518234)
Jefferson R. Wilson (331489)
Michael G. Fehlings (142465)

April 2019

These density plots demonstrate the distribution of the key features between the patients who did (b...

Pre-treatment mean DCE parameters in 43 primary sites and 40 nodal sites correlated with SF or SC at the same SCC site, based on a minimum of 2 year clinical follow-up.

Abstract

Extracted data

Pre-treatment mean DCE parameters in 43 primary sites and 40 nodal sites correlated with SF or SC at the same SCC site, based on a minimum of 2 year clinical follow-up.

Abstract

Extracted data

Related items

Related items